VIENNA, Austria, September 21 /PRNewswire/ -- EUCODIS Bioscience, a company developing, customizing, manufacturing, and marketing enzymes for the chemical industry, announced today that it has launched the first enzymes of its lipase portfolio. EUCODIS Bioscience currently offers 12 lipases that have been selected to cover a broad range of potential industrial applications.
Lipases are an enzyme family that is widely used across the chemical industry, including the pharmaceutical, cosmetics, textiles, and food and feed industries. EUCODIS Bioscience offers customers to supply lipases of interest up to the kilogram scale. The Company can also customize promising lipases to properties specified by the customer, using its proven in-vivo recombination technology.
"With the launch of our lipases portfolio we enter a market of USD 300 million," said Rudy Pandjaitan, PhD, CEO of EUCODIS Bioscience. "In recent years our organization has accumulated a unique expertise in the development, customization, and manufacturing of industrial lipases. Our customers can select from our portfolio of currently 12 lipases which include both enzymes designed for well-established uses as well as those with exciting novel properties. Going forward we plan to expand our lipase platform and to leverage the industrial expertise we can offer in this area."
About EUCODIS Bioscience
EUCODIS Bioscience GmbH develops, customizes, manufactures, and markets industrial enzymes.
EUCODIS Bioscience' products help customers in the chemical, pharmaceutical, and food and feed industries to make manufacturing processes more efficient and cleaner, and to generate products with superior properties.
EUCODIS Bioscience originally focused on developing enzymes for industrial partners, including GlaxoSmithKline, Henkel, and Lohmann Animal Health. Since 2009, the Company also markets its own products.
Led by an experienced management team, EUCODIS Bioscience is backed by Austrian and German institutional venture capital funds, founders, and private investors. The Company is headquartered in Austria, Europe, with subsidiaries in France and Germany.
SOURCE EUCODIS Bioscience
CONTACT: Company contact EUCODIS Bioscience: Rudy Pandjaitan, PhD, CEO,
EUCODIS Bioscience, Campus Vienna Biocenter II, Viehmarktgasse 2 a/ 2 OG,
A-1030 Vienna, AUSTRIA, +43-1-8900804, email@example.com; Media
contact EUCODIS Bioscience: Frank Butschbacher, Investor Relations &
Communications, http://www.butschbacher.net, +43-650-7844940,